BioCentury
ARTICLE | Company News

Eli Lilly, Merck KGaA deal

January 26, 2004 8:00 AM UTC

MRK subsidiary Biovation Ltd. (Aberdeen, U.K.) will apply its DeImmunisation technology to undisclosed biopharmaceuticals designed by LLY. Biovation will receive research revenues and is eligible for...